Antithrombotic Pharmacotherapy Traineeship

The traineeship's application cycle will open in Summer 2015; more information to come.

Program Overview
The Antithrombotic Pharmacotherapy Traineeship is a postgraduate, 5-day structured experiential program for pharmacists. The traineeship prepares participants to provide pharmaceutical care to patients at risk for cardiac or thromboembolic events by designing patient-specific pharmacotherapy; solving drug therapy problems; and developing protocols, policies, and procedures for the treatment of these patients. The primary goal of the traineeship is to prepare pharmacists to establish and maintain specialized services for the management of patients' antithrombotic therapy. The 5-day experiential program is a Level III educational program intended to provide individualized, intensive clinical training for selected practicing pharmacists. It offers the trainee an opportunity to observe and participate in the activities of an established antithrombotic service in a healthcare system. The traineeship program can be used for continuing professional pharmacist development and credentialing. However, continuing education credits are not offered with this traineeship. 

Applicants will be notified if they are accepted approximately 8 weeks after the close of the application period.   


Application Process
• Prerequisites for the Antithrombotic Traineeship
• Experiential Training Agreement
Other Educational Opportunities
Supplemental Reading List


More Information About the Traineeship 
Sites and Faculty
Selection Panels 
Selected Trainees
What Our Trainees Say About This Program
• Read "ASHP Research and Education Foundation's Antithrombotic Pharmacotherapy Traineeship: A Trainee's View," by Dale English. Originally published in Am J Health-Syst Pharm. 2008; 65:1508-1510. © 2008, American Society of Health-System Pharmacists, Inc. All rights reserved. Posted with permission.


For More Information About Anticoagulation
For even more information about anticoagulation, visit ASHP's Anticoagulation Resource Center.

From: 
Email:  
To: 
Email:  
Subject: 
Message: